Literature DB >> 18764694

Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.

Courtney L Fitzpatrick1, James P Farese, Rowan J Milner, Marc E Salute, Didier A Rajon, Christopher G Morris, Francis J Bova, David M Lurie, Dietmar W Siemann.   

Abstract

OBJECTIVE: To characterize the radiosensitivity and capacity for sublethal damage repair (SLDR) of radiation-induced injury in 4 canine osteosarcoma cell lines. SAMPLE POPULATION: 4 canine osteosarcoma cell lines (HMPOS, POS, COS 31, and D17). PROCEDURES: A clonogenic colony-forming assay was used to evaluate the cell lines' intrinsic radiosensitivities and SLDR capacities. Dose-response curves for the cell lines were generated by fitting the surviving fractions after radiation doses of 0 (control cells), 1, 2, 3, 6, and 9 Gy to a linear quadratic model. To evaluate SLDR, cell lines were exposed to 2 doses of 3 Gy (split-dose experiments) at an interval of 0 (single 6-Gy dose), 2, 4, 6, or 24 hours, after which the surviving fractions were assessed.
RESULTS: Mean surviving fraction did not differ significantly among the 4 cell lines at the radiation doses tested. Mean surviving fraction at 2 Gy was high (0.62), and the alpha/beta ratios (predictor of tissue sensitivity to radiation therapy) for the cell lines were low (mean ratio, 3.47). The split-dose experiments revealed a 2.8- to 3.9-fold increase in cell survival when the radiation doses were applied at an interval of 24 hours, compared with cell survival after radiation doses were applied consecutively (0-hour interval). CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that these canine osteosarcoma cell lines are fairly radioresistant; alpha/beta ratios were similar to those of nonneoplastic, late-responding tissues. Future clinical investigations should involve increasing the fraction size in a manner that maximizes tumor killing without adverse effects on the nonneoplastic surrounding tissues.

Entities:  

Mesh:

Year:  2008        PMID: 18764694     DOI: 10.2460/ajvr.69.9.1197

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  Proton Radiation Therapy for Local Control in a Case of Osteosarcoma of the Neck.

Authors:  Stanley I Gutiontov; Zachary S Zumsteg; Benjamin H Lok; Sean Berry; Chiaojung J Tsai; Sean M McBride; Nadeem Riaz; Oren Cahlon; Nancy Y Lee
Journal:  Int J Part Ther       Date:  2017-03-14

2.  Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression.

Authors:  Christopher A Lucchesi; Jin Zhang; Demitria M Vasilatis; Elizabeth Yip; Xinbin Chen
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

3.  Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs.

Authors:  Megan E Duffy; Christie L Anderson; Kevin Choy; Janean L Fidel
Journal:  Can Vet J       Date:  2018-02       Impact factor: 1.008

4.  Cellular and phenotypic characterization of canine osteosarcoma cell lines.

Authors:  Marie E Legare; Jamie Bush; Amanda K Ashley; Taka Kato; William H Hanneman
Journal:  J Cancer       Date:  2011-05-04       Impact factor: 4.207

5.  Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs.

Authors:  Tiffany Wormhoudt Martin; Lynn Griffin; James Custis; Stewart D Ryan; Mary Lafferty; Mary-Keara Boss; Daniel Regan; Sangeeta Rao; Del Leary; Stephen J Withrow; Susan M LaRue
Journal:  Vet Comp Oncol       Date:  2021-01-13       Impact factor: 2.385

6.  Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.

Authors:  Fernanda B Mantovani; Jodi A Morrison; Anthony J Mutsaers
Journal:  BMC Vet Res       Date:  2016-05-31       Impact factor: 2.741

7.  Evaluation of tumor volume reduction of nasal carcinomas versus sarcomas in dogs treated with definitive fractionated megavoltage radiation: 15 cases (2010-2016).

Authors:  Matthew J Morgan; David M Lurie; Armando J Villamil
Journal:  BMC Res Notes       Date:  2018-01-24

8.  Genomic instability and telomere fusion of canine osteosarcoma cells.

Authors:  Junko Maeda; Charles R Yurkon; Hiroshi Fujisawa; Masami Kaneko; Stefan C Genet; Erica J Roybal; Garrett W Rota; Ethan R Saffer; Barbara J Rose; William H Hanneman; Douglas H Thamm; Takamitsu A Kato
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.